FDA Approves 2nd Drug for Treatment of Chronic HCV
Share
Follow Us
The Editors at Hepatitis Central
December 9, 2013
Find out about Sovaldi (sofosbuvir), the second drug the FDA has approved since the end of November for the treatment of Hepatitis C.
FDA approves breakthrough drug for treatment of hepatitis C
By Elizabeth Landau, CNN
Fri December 6, 2013
(CNN) — The U.S. Food and Drug Administration approved a breakthrough drug Friday to treat chronic hepatitis C virus infection.
Sovaldi (sofosbuvir) is the first drug that has been shown to safely and effectively treat certain types of hepatitis C infection without a need for interferon, the FDA said.
Continue reading this entire article:
http://www.cnn.com/2013/12/06/health/fda-hepatitis-c/
